Healthcare Press

The FDA approves an Alzheimer's drug that appears to modestly slow the disease

  • 📰 NPRHealth
  • ⏱ Reading Time:
  • 1 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 4%
  • Publisher: 63%

Health Health Headlines News

Health Health Latest News,Health Health Headlines

The Food and Drug Administration has approved an Alzheimer's drug that appears to modestly slow down the disease. (Story aired on Weekend Edition Saturday on Jan. 6, 2023.)

The Food and Drug Administration has approved an Alzheimer's drug that appears to modestly slow down the disease.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 144. in HEALTH

Health Health Latest News, Health Health Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

U.S. FDA approves Alzheimer's drug that appears to slow rate of cognitive declineThe drug, to be sold under the brand Leqembi, belongs to a class of treatments that aims to slow advance of the neurodegenerative disease by removing sticky clumps of the toxic protein beta amyloid from the brain.
Source: TheStarPhoenix - 🏆 253. / 63 Read more »

FDA Approves New Alzheimer's Drug Designed to Slow Cognitive Decline​The US Food and Drug Administration (FDA) on Friday approved a highly anticipated new drug designed to slow cognitive decline in patients in mild and early stages of Alzheimer's disease. Better just to look after your head.
Source: ScienceAlert - 🏆 63. / 68 Read more »